COVID-19 updates, including vaccine information, for our patients and visitors Learn More
View All Releases >
UC San Diego researchers describe the underlying signaling pathway that results in pulmonary arterial hypertension and a novel monoclonal antibody therapy that blocks the abnormal blood vessel formati ...
Trauma physicians at UC San Diego Health attribute the rise in injuries to a height increase of the border wall at U.S.-Mexico border.
Researchers at UC San Diego School of Medicine report that high-frequency spinal cord stimulation proved more effective at improving perceived pain reduction than low-frequency SCS in patients studied ...
Epilepsy treatment, and hopefully quality of life for one 18-year-old patient, receives robotic boost at UC San Diego Health.
UC San Diego Health announces the opening of a new, multi-disciplinary clinic for patients with gastrointestinal and digestive diseases. The state-of-the-art clinic is the first of its kind in San Die ...
View All Features >
The team at UC San Diego Health takes a family centered approach to treating children for burns that ensures the social, emotional and psychological needs are met for pediatric patients and their fami ...
María Madrigal, receptora de riñón donante, estaba plagada de bacterias multirresistentes; un tratamiento emergente llamado terapia con bacteriófagos resultó ser el remedio.
Donor kidney recipient Maria Madrigal was plagued by multidrug-resistant bacteria; an emerging treatment called phage therapy proved to be the remedy.
Convalescent therapy is a century-old approach adapted to potentially treating and preventing COVID-19 by boosting patients’ neutralizing antibodies. Edward Cachay, MD, leads a clinical trial at UC Sa ...
In the News
View More >
Features Susan Little, MD
Features UC San Diego Health
Authored by Khai Nguyen, MD
Features Scott Lippman, MD, and David Crawford, MD
Features Caitlin Costello, MD